Doris Quackenbush - 07 May 2026 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: Sales VP
Issuer ticker: AXGN
Reported as of: 07 May 2026
Net transaction value: -$168,720
SEC form: 4
Accepted by SEC: 08 May 2026, 16:06:27 UTC
Prior SEC filing: 08 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Began, as attorney-in-fact for Doris Quackenbush

Key filing fact

Doris Quackenbush filed Form 4 for Axogen, Inc. (AXGN) on 08 May 2026.

Key facts

This page summarizes Doris Quackenbush's Form 4 filing for Axogen, Inc. (AXGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 May 2026, 16:06.

Change

Previous filing in this sequence was filed on 08 May 2026.
Current net transaction value: -$168,720.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002133244 Primary reporting owner

Quackenbush Doris

Relationship: Sales VP
Address: 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA
Signature: /s/ Marc Began, as attorney-in-fact for Doris Quackenbush
Signature date: 08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Sale

Transaction value: $168,720
Shares: -3,878
Change %: -4%
Price: $43.51
Shares after: 92,416
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.50 to $44.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.